wegovy a glp 1 Novo Nordisk launches weight-loss pill in US, triggering price war | Pharmaceuticals industry Professor Receives Grant to Study

A systematic review and meta-analysis: the effects of probiotic supplementation on metabolic profile in patients with neurological disorders

October 29 Product: Novartis Scemblix Indication: Chronic myeloid leukemia Novartis Scemblix is now a first-line treatment option for certain patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase after the FDA granted a label expansion Tuesday

Glutathione is known to have anti-inflammatory properties and can help to reduce inflammation levels

474 At week 8, patients with moderate to severe UC treated with 45 mg upadacitinib showed significant improvement, with 46% reporting no intestinal urgency and 38% reporting no symptoms of abdominal pain

Enrichment analysis revealed marked upregulation of multiple central metabolic pathways, including the glycolytic and tricarboxylic acid cycle pathways